StonvexLoading…
StonvexStonvexStonvexCore line items from TYL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $613.50M | $2.33B | $1.76B | $1.16B |
Operating Income | $99.81M | $357.68M | $282.70M | $184.77M |
Net Income | $81.18M | $315.60M | $250.07M | $165.68M |
EPS (Diluted) | $1.88 | $7.20 | $5.70 | $3.76 |
Total Assets | $4.80B | $5.64B | $5.46B | $5.43B |
Total Liabilities | $1.24B | $1.94B | $1.85B | $1.79B |
Cash & Equivalents | $316.01M | $1.02B | $834.10M | $787.45M |
Free Cash Flow OCF − CapEx | $104.03M | $637.53M | $397.96M | $146.65M |
Shares Outstanding | 48.15M | 48.15M | 48.15M | 48.15M |